• Oxford Genetics collaborates with Sphere Fluidics, the University of Edinburgh & Twist Bioscience to develop next-generation, microfluidic enabled gene editing workflows
  • Oxford Genetics announces the appointment of their new Chief Operating Officer
  • New Standardized Plasmids Available for Lentiviral Manufacturing
  • Influenza, the difficulty of producing effective vaccines, and recent innovation in flu vaccines
  • DNA origami: from novelty item to novel applications
  • Genome Editing: One Small Needle for Brian, One Giant Injection For Gene Therapy
Subscribe to our newsletter